MAPK13-IN-1

CAS No. 229002-10-2

MAPK13-IN-1( —— )

Catalog No. M33008 CAS No. 229002-10-2

MAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 258 In Stock
2MG 140 In Stock
5MG 235 In Stock
10MG 353 In Stock
25MG 611 In Stock
50MG 867 In Stock
100MG 1265 In Stock
200MG Get Quote In Stock
500MG 2530 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MAPK13-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    MAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).
  • Description
    MPAK13-IN-1 is a MAPK13 (p38δ) inhibitor, with an IC50 of 620 nM.
  • In Vitro
    Cell Viability Assay Cell Line:Vero E6 cells.Concentration:0-100 μM.Incubation Time:Result:Exhibited an IC50 of 4.63 μM.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    p38 MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    229002-10-2
  • Formula Weight
    365.43
  • Molecular Formula
    C20H23N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 250 mg/mL (684.13 mM)
  • SMILES
    Cn1nc(cc1NC(=O)Nc1ccc(Oc2ccncc2)cc1)C(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yurtsever Z, et al. First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. Biochim Biophys Acta. 2016 Nov;1860(11 Pt A):2335-2344.?
molnova catalog
related products
  • Pamapimod

    A potent, selective, orally bioavailable p38α MAPK inhibitor with Kd of 0.2 nM.

  • TAK1-IN-3

    TAK1-IN-3 is a novel ATP-competitive TAK1 inhibitor for the study of cancer.

  • UR13870

    UR-13870 (Org 48762-0) is an orally active and selective inhibitor of p38 mitogen-activated protein kinase (MAPK), which prevents bone damage in collagen-induced arthritis in mice.